Prospector Partners LLC has sharply increased its exposure to Pfizer Inc., buying nearly 54,000 additional shares in the first quarter, according to a recent regulatory filing. The purchase lifts the fund’s stake by 60.9 percent to 142,455 shares, now valued at about $3.61 million.

In the competitive landscape of the “DIVERSIFIED OPS” industry, Orkla Asa (ORKLY) stands among 52 publicly-traded companies. This article delves into how Orkla Asa measures up against its rivals based on key financial metrics.

As one of 95 publicly-traded companies in the Medical Services industry, Bausch + Lomb faces a competitive landscape. This analysis examines how the company compares to its peers based on key financial metrics, including institutional ownership, profitability, earnings, risk, dividends, valuation, and analyst recommendations.

As one of 300 publicly-traded companies in its industry, Metagenomi (NASDAQ: MGX) faces stiff competition. We delve into how it measures up against its peers in key financial metrics.